-
201
-
202
-
203
-
204
-
205
Epidemiological Changes in Hospitalized Bronchiolitis in Children Under 2 Years of Age in Hangzhou Before and After COVID-19 Restriction Easing
Published 2025-02-01“…This study aimed to analyze the changes in the viral etiology of bronchiolitis in Hangzhou during the COVID-19 restriction period (2022) compared to the period following the easing of restrictions(2023).Methods: This study collected data on patients under 2 years of age who were admitted for bronchiolitis to the Department of Pulmonology at the Children’s Hospital, Zhejiang University School of Medicine (Hangzhou) from January, 1, 2022, to December 31, 2023. …”
Get full text
Article -
206
Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Populat...
Published 2025-02-01“…Rong-Hua Wang,1 Yin Chen,1 Ya-Ling Lou,1 Yu-Liang Lu,2 Hui-Min Xu3 1Department of Pharmacy, HuZhou Central Hospital (The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University), Huzhou, People’s Republic of China; 2Department of Cardiology, HuZhou Central Hospital (The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University), Huzhou, People’s Republic of China; 3Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence: Rong-Hua Wang, Department of Pharmacy HuZhou Central Hospital (The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University), No. 1558 Sanhuan North Road, Wuxing District, Huzhou, Zhejiang, 313000, People’s Republic of China, Email legend.blue@163.com Hui-Min Xu, Department of Pharmacy Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Shangcheng District, Hangzhou, Zhejiang, 310009, People’s Republic of China, Email xuhuimin78@zju.edu.cnPurpose: This study aimed to elaborate on the incidence, clinical features, and management of immune checkpoint inhibitors (ICIs) related cardiovascular adverse events (CVAEs) in real-world practice.Patients and Methods: We performed a retrospective chart review study on patients receiving at least one dose of ICI therapy at a Chinese tertiary hospital from March 2020 to March 2021. …”
Get full text
Article -
207
-
208
Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses
Published 2025-02-01Get full text
Article -
209
Novel inhibitors of the (VIBVN) NAT protein identified through pharmacophore modeling
Published 2025-01-01Get full text
Article -
210
A Rare Case of Anterior Wall Combined With Inferior Wall Wellens Syndrome
Published 2025-01-01Get full text
Article -
211
Editorial: Progressing the understanding and management of bloodstream infections
Published 2025-02-01Get full text
Article -
212
-
213
-
214
-
215
-
216
-
217
Management of periodontal hard tissue related complications in orthodontic treatment
Published 2025-01-01Get full text
Article -
218
-
219
-
220
GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer
Published 2025-02-01Get full text
Article